Development of Thiadiazole as an Antidiabetic Agent- A Review

Author(s): Prasanna A. Datar, Tejashree A. Deokule

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 14 , Issue 2 , 2014

Become EABM
Become Reviewer


This review provides a brief summary of thiadiazole ring containing compounds as antidiabetic agents. It covers the most active thiadiazole derivatives selected from reported literature of thiadiazole system as antidiabetic drug substance in the form of synthesis and structural activity relationship study reports. Some of the promising thiadiazole compounds interacting with targets such as sodium-glucose linked transporter, peroxisome proliferator-activated receptor, protein tyrosine phosphatase, c-Jun N-terminal kinase, dipeptidyl peptidase-4 and cannabinoid-1 receptor have been collected with their biological potency. The information provided in this review acts as important overview for medicinal chemist to develop a new chemical entity possessing antidiabetic activity.

Keywords: Antidiabetic, cannabinoid-1 receptor, c-Jun N-terminal kinase, dipeptidyl peptidase-4, peroxisome proliferatoractivated receptor, protein tyrosine phosphatase, sodium-glucose linked transporter, thiadiazole.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 04 February, 2014
Page: [136 - 153]
Pages: 18
DOI: 10.2174/1389557513666140103102447
Price: $65

Article Metrics

PDF: 28